Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$116.88B | 27.8x | 2.51 | A$241.18 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.97B | 27x | -5.31 | A$34.23 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.5% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$4.94B | -315x | 8.01 | A$3.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.5% Downside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | A$1.71B | 12.5x | -1.28 | A$13.76 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$633.36M | -16x | 0.09 | A$0.32 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$522.10M | 13.6x | 0.44 | A$10.43 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mayne Pharma | Sydney | Healthcare | Pharmaceuticals | A$419.23M | -3.5x | -0.08 | A$5.14 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
AFT Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$262.17M | 24.5x | -0.96 | A$2.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vita Life Sciences | Sydney | Healthcare | Pharmaceuticals | A$118.07M | 13.4x | -2.34 | A$2.14 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biome Australia | Sydney | Healthcare | Pharmaceuticals | A$98.70M | 463.8x | 3.2 | A$0.46 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recce | Sydney | Healthcare | Pharmaceuticals | A$95.16M | -3.7x | 0.11 | A$0.33 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Sydney | Healthcare | Pharmaceuticals | A$71.38M | -4.9x | 0.07 | A$0.14 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medical Developments | Sydney | Healthcare | Pharmaceuticals | A$65.91M | -1.9x | 0.06 | A$0.58 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Radiopharm Theranostics | Sydney | Healthcare | Pharmaceuticals | A$56.02M | -0.8x | -0.01 | A$0.03 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inoviq | Sydney | Healthcare | Pharmaceuticals | A$48M | -6.1x | -3.92 | A$0.43 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vitura Health | Sydney | Healthcare | Pharmaceuticals | A$43.71M | 22x | -0.29 | A$0.07 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Pharmaceuticals | A$40.07M | -4.6x | -0.27 | A$0.17 | -7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Starpharma Holdings | Sydney | Healthcare | Pharmaceuticals | A$38.06M | -3x | 0.08 | A$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Little Green Pharma | Sydney | Healthcare | Pharmaceuticals | A$34.96M | 10x | 0.07 | A$0.12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 50% Upside | Upgrade to Pro+ | |
Next Science | Sydney | Healthcare | Pharmaceuticals | A$19.28M | -1.7x | -0.03 | A$0.07 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Firebrick Pharma | Sydney | Healthcare | Pharmaceuticals | A$18.42M | -7.6x | -0.14 | A$0.09 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immuron Ltd | Sydney | Healthcare | Pharmaceuticals | A$16.61M | -2.3x | 0.02 | A$0.07 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Althea | Sydney | Healthcare | Pharmaceuticals | A$13.57M | -0.6x | -0.02 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncosil Medical Ltd | Sydney | Healthcare | Pharmaceuticals | A$11.29M | -0.6x | -0.02 | A$0.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acrux | Sydney | Healthcare | Pharmaceuticals | A$9.38M | -1.1x | 0 | A$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Calmer Co International | Sydney | Healthcare | Pharmaceuticals | A$7.66M | -2.5x | -0.02 | A$0.003 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argent BioPharma | Sydney | Healthcare | Pharmaceuticals | A$6.42M | -0.2x | -0 | A$0.09 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TrivarX | Sydney | Healthcare | Pharmaceuticals | A$6.17M | -13.6x | -0.17 | A$0.010 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hydration Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$3.45M | -0.3x | -0 | A$0.010 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nutritional Growth | Sydney | Healthcare | Pharmaceuticals | A$3.39M | -0.4x | -0.01 | A$0.03 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imagion Biosystems | Sydney | Healthcare | Pharmaceuticals | A$2.21M | -0.2x | -0.01 | A$0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anatara Lifesciences Ltd | Sydney | Healthcare | Pharmaceuticals | A$1.07M | -0.5x | -0.02 | A$0.005 | -16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |